Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,190.00
Bid: 12,210.00
Ask: 12,214.00
Change: 162.00 (1.35%)
Spread: 4.00 (0.033%)
Open: 12,036.00
High: 12,214.00
Low: 12,024.00
Prev. Close: 12,028.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-COVID-19 vaccine hopes lift world stocks, dollar eases

Mon, 14th Sep 2020 16:59

* AstraZeneca, Pfizer vaccine news lifts equities

* UK, US, Japan central banks meet this week

* Japan's Suga wins ruling party leadership race

* UK parliament to vote on plan to break Brexit divorce
treaty

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh

By Herbert Lash

NEW YORK, Sept 14 (Reuters) - The dollar weakened and world
stock markets rose on Monday on encouraging signs of progress in
developing a COVID-19 vaccine, while several multi-billion
dollar deals also help lift the spirit of investors after last
week's downdraft.

Gold edged higher and bond yields were stable as investors
gauge how the U.S. Federal Reserve will put its new approach to
monetary policy into practice and keep its dovish stance at this
week's policy meeting.

Pfizer Inc and BioNTech SE on Saturday
proposed expanding their Phase 3 pivotal COVID-19 vaccine trial
to about 44,000 participants, while increasing the diversity of
the trial population.

Drugmaker AstraZeneca said over the weekend it has
resumed British clinical trials of its COVID-19 vaccine, one of
the most advanced in development, after getting the green light
from safety watchdogs.

"The market reacts positively to any vaccine news," said Tim
Ghriskey, chief investment strategist at Inverness Counsel in
New York. "We're going to see a lot more vaccines come out, and
that is what really is helping the markets."

The World Health Organization reported a record one-day
increase in global coronavirus cases on Sunday, with the total
rising by 307,930 in 24 hours. The biggest increases were from
India, the United States and Brazil.

"There is still some caution in markets because U.S. virus
numbers appear to be picking up again in some states," said
Seema Shah, chief strategist at Principal Global Investors.

"The vaccine news is positive but there is a lot of
skepticism about when they become widely adopted," Shah said.

Plans by Nvidia Corp to buy UK-based chip designer
Arm from Japan's SoftBank Group Corp for as much as $40
billion, a deal expected to reshape the global semiconductor
landscape, also drove sentiment. Nvidia shares
jumped 6.6%.

Oracle surged 5.4% as the cloud services company
said it would team up with China's ByteDance to keep TikTok
operating in the United States, beating Microsoft Corp
in a deal structured as a partnership rather than an outright
sale.

MSCI's benchmark for global equity markets
rose 1.38% to 573.79, while in Europe the broad FTSEurofirst 300
index added 0.07% at 1,429.

On Wall Street, the Dow Jones Industrial Average rose
1.31%, the S&P 500 gained 1.68% and the Nasdaq Composite
added 2.33%.

Overnight in Asia, MSCI's broadest index of Asia-Pacific
shares outside Japan rose 0.9% to its highest in
almost a week. Japan's Nikkei firmed 0.7% after Chief
Cabinet Secretary Yoshihide Suga won a landslide victory in a
ruling party leadership election, paving the way for him to
succeed Prime Minister Shinzo Abe.

The Fed starts a two-day policy meeting on Tuesday, the
first since unveiling a landmark shift to a more tolerant stance
on inflation in August. The Bank of Japan and the Bank of
England announce their respective policy decisions on Thursday.

Sterling, which has been hurt by renewed Brexit turmoil,
firmed before a vote on British Prime Minister Boris Johnson's
plan to break international law by breaching parts of the Brexit
divorce treaty with the European Union.

Sterling was last trading at $1.2873, up 0.63% on the
day, while the dollar index fell 0.294%.

The euro was up 0.23% to $1.1872, and the Japanese
yen strengthened 0.51% versus the greenback at 105.67 per
dollar.

Turkey's lira set a record low against the U.S. dollar
and its dollar bonds came under pressure after Moody's
cut the country's sovereign rating and warned of the risk of a
balance of payment crisis.

Oil prices slipped amid concerns about a stalled global
economic recovery and falling fuel demand as Libya signaled it
would end its months-long blockade and resume output, adding yet
more supply to the market.

Brent crude futures fell $0.22 to $39.61 a barrel.
U.S. crude futures slid $0.11 to $37.22 a barrel.

Spot gold prices rose 0.85% to $1,958.04 an ounce.

(Reporting by Herb Lash; additional reproting by Dhara
Ranasinghe; Editing by Peter Graff, Bernadette Baum and Dan
Grebler)

More News
23 Oct 2023 08:45

TOP NEWS: AstraZeneca says Enhertu approved by European Commission

(Alliance News) - AstraZeneca PLC on Monday said its Enhertu treatment has been approved by the European Commission to treat adult lung cancer patients.

Read more
23 Oct 2023 07:46

LONDON BRIEFING: Keller expects higher profit; Upland rejects approach

(Alliance News) - Stocks in London are set to open slightly higher on Monday, as risk sentiment improves after a difficult period for markets last week.

Read more
18 Oct 2023 09:04

AstraZeneca drug Solaris approved in China as NMOSD treatment

(Alliance News) - AstraZeneca PLC on Wednesday announced that eculizumab, whose brand name is Solaris, has been approved in China to treat patients with neuromyelitis optica spectrum disorder

Read more
17 Oct 2023 12:06

LONDON MARKET MIDDAY: European markets uneasy but FTSE 100 outperforms

(Alliance News) - London's FTSE 100 higher was higher around midday, though it was defensive stocks such as utilities and pharmaceuticals which led the charge, suggesting there is still lingering discomfort in markets amid tensions in the Middle East.

Read more
16 Oct 2023 08:34

TOP NEWS: AstraZeneca's cancer drug gets priority review from US FDA

(Alliance News) - AstraZeneca PLC on Monday said that its new drug application for Tagrisso has been granted priority review in the US, after trial results extended progression-free survival.

Read more
4 Oct 2023 12:14

IN BRIEF: AstraZeneca's Forxiga drug shows positive results in trial

AstraZeneca PLC - Cambridge-based pharmaceutical maker - Says Forxiga drug meets primary endpoints in T2NOW phase three trial and shows "clinically meaningful" improvements in the glycaemic control among type two diabetes patients between the ages of 10 and 17. Adds safety results in patient cohort were consistent with those in adults with type two diabetes.

Read more
3 Oct 2023 16:55

LONDON MARKET CLOSE: Stocks red as rate rise fears continue to grow

(Alliance News) - Stocks in London were lower at the close on Tuesday after unexpectedly strong US job openings data added to fears that interest rates in the world's largest economy will stay higher for longer.

Read more
3 Oct 2023 11:59

LONDON MARKET MIDDAY: HSBC and StanChart help FTSE 100 outperform

(Alliance News) - London's FTSE 100 grew in confidence as Tuesday morning progressed, going into the afternoon in the green and outperforming European peers.

Read more
3 Oct 2023 08:36

TOP NEWS: AstraZeneca settles Nexium and Prilosec litigation

(Alliance News) - AstraZeneca PLC on Tuesday said it has settled legal matters involving its Nexium acid reflux and Prilosec heartburn products, parting with USD425 million.

Read more
3 Oct 2023 07:41

LONDON BRIEFING: Greggs sales rise; boohoo cuts revenue outlook

(Alliance News) - London's FTSE 100 is set to fall further on Tuesday, after a sell-off at the start of the week, with hawkish words from a US central banker reinforcing the 'higher-for-longer' interest rates messaging.

Read more
3 Oct 2023 07:24

AstraZeneca agrees to settle most Nexium, Prilosec claims

(Sharecast News) - Global pharmaceutical company AstraZeneca has agreed to settle litigation on product liability related to two of its widely-used heartburn drugs, Nexium and Prilosec, it announced on Tuesday.

Read more
25 Sep 2023 09:13

LONDON BROKER RATINGS: Jefferies raises AstraZeneca to 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning:

Read more
25 Sep 2023 07:43

LONDON BRIEFING: Stocks seen lower; Aviva buys AIG's UK protection arm

(Alliance News) - Stocks in London were set to open lower on Monday as investors eyed fresh concerns for the already fragile Chinese property sector.

Read more
22 Sep 2023 08:42

LONDON MARKET OPEN: Stocks slip after central bank rate calls

(Alliance News) - Stock prices in London opened lower on Friday, but managed to avoid the steep declines seen in New York, as investors mulled over an eventful week dominated by central bank decisions.

Read more
22 Sep 2023 08:13

TOP NEWS: AstraZeneca's datopotamab deruxtecan shows positive results

(Alliance News) - AstraZeneca PLC on Friday said phase three data showed that datopotamab deruxtecan delivered improvement in progression-free survival in breast cancer patients.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.